Olsen Kipp Josephine, Hanberg Pelle, Slater Josefine, Møller Nielsen Line, Storgaard Jakobsen Stig, Stilling Maiken, Bue Mats
Orthopaedic Research Unit, Aarhus University Hospital, Palle Juul-Jensens Blvd. 99, 8200 Aarhus N, Denmark.
Department of Orthopaedic Surgery, Horsens Regional Hospital, Sundvej 30, 8700 Horsens, Denmark.
J Bone Jt Infect. 2021 Feb 12;6(4):99-106. doi: 10.5194/jbji-6-99-2021. eCollection 2021.
. Systemic perioperative vancomycin may not provide sufficient prophylactic target-site concentrations in the prevention of prosthetic joint infections. Intraosseous vancomycin potentially provides high target-site concentrations. The objective of the present study was to evaluate the local bone and tissue concentrations following tibial intraosseous vancomycin administration in a porcine model. . Eight pigs received 500 mg diluted vancomycin (50 mg/mL) through an intraosseous cannula into the proximal tibial cancellous bone. No tourniquet was applied. Microdialysis was applied for sampling of vancomycin concentrations in adjacent tibial cancellous bone, in cortical bone, in the intramedullary canal of the diaphysis, in the synovial fluid of the knee joint, and in the subcutaneous tissue. Plasma samples were obtained as a systemic reference. Samples were collected for 12 h. . High vancomycin concentrations were found in the tibial cancellous bone with a mean peak drug concentration of 1236 (range 28-5295) , which remained high throughout the sampling period. The mean (standard deviation) peak drug concentration in plasma was 19 (2) , which was obtained immediately after administration. Peak drug concentration, time to peak drug concentration, and area under the concentration-time curve were within the same range in the intramedullary canal, the synovial fluid of the knee, and the subcutaneous tissue. . Tibial intraosseous administration of vancomycin provided high concentrations in tibial cancellous bone throughout a 12 h period but with an unpredictable and wide range of peak concentration. The systemic absorption was high and immediate, thus mirroring an intravenous administration. Low mean concentrations were found in all the remaining compartments.
围手术期全身性使用万古霉素在预防人工关节感染时可能无法提供足够的预防靶位浓度。骨内注射万古霉素可能会提供较高的靶位浓度。本研究的目的是在猪模型中评估胫骨骨内注射万古霉素后局部骨和组织中的浓度。8头猪通过骨内套管将500mg稀释的万古霉素(50mg/mL)注入近端胫骨松质骨。未使用止血带。采用微透析法采集相邻胫骨松质骨、皮质骨、骨干髓腔、膝关节滑液和皮下组织中万古霉素的浓度样本。采集血浆样本作为全身对照。样本采集12小时。在胫骨松质骨中发现万古霉素浓度较高,平均药物峰浓度为1236(范围28 - 5295)μg/mL,在整个采样期间一直保持较高水平。给药后立即测得血浆中平均(标准差)药物峰浓度为19(2)μg/mL。骨髓腔、膝关节滑液和皮下组织中的药物峰浓度、达峰时间和浓度 - 时间曲线下面积在同一范围内。胫骨骨内注射万古霉素在12小时内胫骨松质骨中均能提供高浓度,但峰浓度不可预测且范围较宽。全身吸收迅速且程度高,因此类似于静脉注射。在所有其他腔室中测得的平均浓度较低。